Serum aminotransferases are used to evaluate hepatic injury indirectly, but are limited because 15–30% of CHC patients have consistently normal alanine aminotransferase (ALT) despite the presence of liver inflammation [7], [8]. This evidence concerns the gene GPT and Hepatitis.